Oxford and AstraZeneca’s Covid-19 vaccine to be trialed AGAIN amid mounting questions over dosage issues

The Covid-19 vaccine being

The Covid-19 vaccine being developed by Oxford University and AstraZeneca will be tested again, the drug maker’s CEO said on Thursday, following growing doubts over the jab, due to dosing and data-handling errors.

The British-Swedish pharmaceutical giant is to run a fresh trial of its candidate vaccine at a lower dosage, which the company earlier claimed had performed better than a full dosage. “Now that we’ve found what looks like a better efficacy we have to validate this, so we need to do an additional study,” AstraZeneca CEO Pascal Soriot told Bloomberg.

Continue reading https://on.rt.com/avxc